2025 KASL clinical practice guidelines for management of hepatitis C
Clin Mol Hepatol
.
2026 Jan;32(1):1-52.
doi: 10.3350/cmh.2025.0777.
Epub 2025 Oct 23.
Authors
Eun Sun Jang
1
,
Nae Yun Heo
2
,
Jae Yoon Jeong
3
,
Jung Gil Park
4
,
Do Seon Song
5
,
Eun Ju Cho
6
,
Chang Hun Lee
7
,
Jae Seung Lee
8
,
Jae Hyun Yoon
9
,
Seul Ki Han
10
,
Young Kul Jung
11
;
Korean Association for the Study of the Liver (KASL)
Affiliations
1
Department of Internal Medicine, Seoul National University Bundang Hospital, Seoul National University College of Medicine, Seongnam, Korea.
2
Department of Internal Medicine, Inje University Haeundae Paik Hospital, Inje University College of Medicine, Busan, Korea.
3
Department of Internal Medicine, Ewha Womans University Mokdong Hospital, Ewha Womans University College of Medicine, Seoul, Korea.
4
Department of Internal Medicine, Yeungnam University Medical Center, Yeungnam University College of Medicine, Daegu, Korea.
5
Department of Internal Medicine, St. Vincent's Hospital, The Catholic University of Korea College of Medicine, Seoul, Korea.
6
Department of Internal Medicine, Seoul National University Hospital, Seoul National University College of Medicine, Seoul, Korea.
7
Department of Internal Medicine, Jeonbuk National University Hospital, Jeonbuk National University College of Medicine, Jeonju, Korea.
8
Department of Internal Medicine, Severance Hospital, Yonsei University College of Medicine, Seoul, Korea.
9
Department of Internal Medicine, Chonnam National University Hospital, Chonnam National University College of Medicine, Gwangju, Korea.
10
Department of Internal Medicine, Wonju Severance Christian Hospital, Yonsei University Wonju College of Medicine, Wonju, Korea.
11
Department of Internal Medicine, Korea University Ansan Hospital, Korea University College of Medicine, Ansan, Korea.
PMID:
41126716
PMCID:
PMC12835810
DOI:
10.3350/cmh.2025.0777
No abstract available
Keywords:
Direct acting antivirals; Guidelines; Hepatitis C; Treatment.